Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 27 results for "eli lilly"

Alembic Pharma gets USFDA nod for generic antidepressant drug
Money Control

Alembic Pharma gets USFDA nod for generic antidepressant drug

The approval is for the generic version of Eli Lilly and Company#39;s Prozac tablets in the same strengths, Alembic Pharma said in a BSE filing today. Money Control, 1 month ago

332 images for eli lilly

Mideast Time, 3 months ago
American Banking News, 3 months ago
CNBC, 3 months ago
Post Online Media, 3 months ago
Post Online Media, 3 months ago
WKRB News, 3 months ago
Live Trading News, 3 months ago
American Banking News, 3 months ago
American Banking News, 3 months ago
Post Online Media, 3 months ago

Eli Lilly plans $ 850 million investment for expansion in US

To invest $85 mn to expand its Trulicity (dulaglutide) device assembly operations in Indianapolis BS B2B Bureau | Indianapolis, USA March 29, 2017 Last Updated at 11:24 IST Eli Lilly and Company will invest $ 850 million for expansion of its US operations - ...
 Business Standard1 month ago Drugmaker Lilly to invest $850 million in U.S. operations in 2017  Reuters2 months ago

Eli Lilly launches 200U/mL pre-filled insulin pen

Pharma major Eli Lilly and Company today announced launch Humalog 200U/mL KwikPen -- used in the treatment of diabetes -- in the Indian market. Humalog 200U/mL KwikPen is a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin ...
 Business Standard2 months ago

Lilly migraine treatment meets main goal in late-stage studies

Eli Lilly and Co said on Friday patients with episodic and chronic migraine reported fewer debilitating headaches after using the drugmaker's experimental drug compared to those on placebo. About 40 million Americans suffer from migraines, and the disease ...
 Reuters2 weeks ago Lilly reports positive interim data on breast cancer combo drug  Reuters1 month ago Lilly's breast cancer drug combination succeeds key study  Reuters2 months ago

Billions saved because FDA didn't rush approval of Alzheimer's drug

The U.S. Food and Drug Administration's decision not to rush approval for Eli Lilly's experimental Alzheimer's treatment solanezumab - a drug that turned out to be ineffective - may have saved American taxpayers as much as $100 billion over the past four ...
 Reuters2 weeks ago U.S. FDA declines to approve Eli Lilly and Incyte arthritis drug Olumiant  Reuters1 month ago

Profit profile helps Lilly shares rebound from Alzheimer's setback

Shares of Eli Lilly & Co have staged a dramatic rebound following massive disappointment for its experimental Alzheimer's medicine late last year, outperforming rivals as investors warm to the drugmaker's profit outlook. Investors are counting on Lilly's ...
 Reuters1 month ago
Sify

US STOCKS-Wall Street looks set to open slightly higher

* Oil prices pare losses * Most European financial markets closed for Easter holiday * Incyte, Lilly drop after FDA rejects drug * Futures up: Dow 24 pts, S&P 2.5 pts, Nasdaq 8.5 pts(Adds details, comments, updates prices) By Yashaswini Swamynathan April 17 ...
 Sify1 month ago US STOCKS-Wall St edges higher as tech, financials gain  Sify1 month ago Wall Street edges higher as tech, financials gain  Sify1 month ago
Money Control

Lupin launches erectile dysfunction drug Cialis

Domestic pharma major Lupin Ltd today launched erectile dysfunction treatment medicine Cialis in India through an exclusive licensing pact with Eli Lilly. Lupin has acquired the rights to market, promote and distribute Lilly's erectile dysfunction (ED) ...
 Business Standard1 week ago Lupin gains after launching erectile dysfunction drug  Business Standard1 week ago

Wall St. rallies in low volume led by banks, tech

By Rodrigo Campos NEW YORK (Reuters) - U.S. stocks bounced back on Monday after the S&P 500 closed the previous session at a two-month low, in a broad rally led by recently beaten-down bank and technology shares. Market focus shifted from geopolitical tension ...
 Sify1 month ago US STOCKS-Wall St rallies in low volume led by banks, tech  Sify1 month ago

US STOCKS-Futures dip on soft U.S. data, geopolitical risks

* Futures down: Dow 15 pts, S&P 2.25 pts, Nasdaq 2.25 pts By Yashaswini Swamynathan April 17 (Reuters) - U.S. stock index futures were slightlylower on Monday as geopolitical concerns and weak economic dataweighed on sentiment, while the first-quarter ...
 Sify1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less